Elías Campo
Director of IDIBAPSResearch group
- Molecular pathology of lymphoid neoplasms Group leader (R4)
About me
Elías Campo is Professor of Pathology and Senior Consultant at the Hospital Clinic of Barcelona, University of Barcelona. His research focuses on the molecular and genetic characterization of lymphoid neoplasms. In the last years his work has concentrated on elucidating the genomic and functional alterations in chronic lymphocytic leukemia, mantle cell lymphoma, and other aggressive lymphomas, their role in the pathogenesis of these diseases and their impact in the clinical management of patients. He has been co-director of the Spanish CLL genome project in the International Cancer Genome Consortium. He is member of the USA National Academy of Medicine since 2018.
Featured publications
-
Molecular map of chronic lymphocytic leukemia and its impact on outcome
Authors:Reference: Nature Genetics 2022. -
The International Consensus Classification of Mature Lymphoid Neoplasms: A Report from the Clinical Advisory Committee
Authors:Reference: Blood 2022. -
Detection of early seeding of Richter transformation in chronic lymphocytic leukemia
Authors:Reference: Nature Medicine 2022. -
IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics
Authors:Reference: Blood 2021. -
Genomic and epigenomic insights into the origin, pathogenesis and clinical behavior of mantle cell lymphoma subtypes
Authors:Reference: Blood 2020. -
IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms
Authors:Reference: Nature Communications 2020. -
CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1- mantle cell lymphoma
Authors:Reference: Blood 2019. -
A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome
Authors:Reference: Blood 2018. -
Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets
Authors:Reference: Leukemia 2018. -
Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia
Authors:Reference: Leukemia 2018.
Featured Projects
-
Molecular Diagnosis, Prognosis, and Therapeutic Targets in Mantle Cell Lymphoma
Principal investigator: Elías Campo GüerriFunder: National Institute of Health (NIH) ; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). Institut d'Investigacions Biomèdiques August Pi i Sunyer (Sede o evento)Code: 1P01CA229100Duration: 01/09/2019 - 31/08/2024 -
Single-cell genomics to comprehensively understand healthy B-cell maturationand transformation to chronic lymphocytic leukemia (BCLLatlas)
Principal investigator: Elías Campo GüerriFunder: European CommissionCode: H2020-ERC-Sy_2018 (810287)Duration: 01/04/2019 - 31/03/2024 -
CLLEvolution: Genomic and epigenomic drivers of disease evolution in chronic lymphocytic leukemia. Targets for clinical intervention
Principal investigator: Elías Campo GüerriFunder: La Caixa FoundationCode: HR17-00221_ LCF/PR/HR17/52150017Duration: 31/12/2018 - 31/12/2022 -
EUCANCan: a federated network of aligned and interoperable infrastructures for the homogeneous analysis, management and sharing of genomic oncology data for Personalised Medicine
Principal investigator: Elías Campo GüerriFunder: European CommissionCode: CE_H2020-SC1_18_1s 825835Duration: 01/01/2019 - 30/06/2023 -
La Medicina Personalitzada a Catalunya-Càncer (MedPerCan). Estudi pilot sobre l'impacte de l'anàlisi genòmica en la pressa de decisions en oncologia.
Principal investigator: Elías Campo GüerriFunder: Generalitat de CatalunyaCode: SLT002/16/00374Duration: 27/03/2017 - 31/12/2023